No change in Fidelity's passive stance; the filing is a routine periodic update. Monitor for any future conversion to a 13D filing, which would signal activist intent.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+5- T+0 · Nov 5 $2.34entry
- T+1 · 11d ago +1.28%α +0.97% · $2.37
- T+5 · 5d ago −14.10%α −17.39% · $2.01
- T+7 · todayOpen
- T+20 · in 17d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
FMR LLC (Fidelity) filed an amended Schedule 13G reporting beneficial ownership of 37,293,854 shares of Sana Biotechnology common stock as of September 30, 2026, representing 12.5% of shares outstanding. This is a routine passive stake update by a major institutional holder; no change in investment intent is indicated.
Key Financial Metrics
Key Facts
- FMR LLC reported beneficial ownership of 37,293,854 shares of Sana Biotechnology common stock as of September 30, 2026.
- The stake represents 12.5% of the outstanding shares.
- Fidelity Growth Company Commingled Pool held 15,131,616 shares (5.1%) of the total outstanding as of the same date.
- The filing is an amendment to a Schedule 13G, confirming passive investment intent under Rule 13d-1(c).
Financial Impact
FMR LLC holds 37,293,854 shares, valued at approximately $91 million based on a $730M market cap and 12.5% stake.
Risk Factors
- No material risks identified from this routine passive stake amendment.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G/A Filing (Primary) | 0000315066-26-002831 |
| Document: 0000315066-26-002831-index-headers.html | 0000315066-26-002831 |
| Document: 0000315066-26-002831-index.html | 0000315066-26-002831 |
| Document: 0000315066-26-002831.txt | 0000315066-26-002831 |
Track record
12 reports on SANA
3 of 5 bullish or bearish reports moved the stock their way by T+20. Best: +13.50% at T+20 after the May 11, 2026 report. 3 of 5 went positive at some point.
Filters
- Nov 5, 202611d ago 8-K Neutral 4/10 Entry $2.37 Now $1.88 −20.68% settles Dec 7
- Nov 5, 202611d ago SC 13G/A Neutral 2/10 Viewing Entry $2.34 Now $1.88 −19.66% settles Dec 4
- Aug 10, 202614w ago 8-K Neutral 5/10 No price data
- Aug 10, 202614w ago Press Release Neutral 4/10 Entry $3.79 to $3.17 Now $1.88 −50.40% ▼ −16.36% −15.30% vs SPY
- May 11, 202627w ago 8-K Neutral 4/10 No price data
- May 11, 202627w ago Press Release Bearish 6/10 Entry $3.26 to $2.82 Now $1.88 +42.33% ▲ +13.50% +11.77% vs SPY
- Apr 24, 202629w ago DEFA14A Neutral 4/10 Entry $3.29 to $3.15 Now $1.88 −42.86% ▼ −4.26% −8.28% vs SPY
- Apr 24, 202629w ago 8-K Neutral 2/10 Entry $3.29 to $3.15 Now $1.88 −42.86% ▼ −4.26% −8.28% vs SPY
- Apr 13, 202631w ago 8-K Bullish 6/10 Entry $3.48 to $3.56 Now $1.88 −45.98% ▲ +2.30% −4.00% vs SPY
- Apr 13, 202631w ago Press Release Bullish 7/10 Entry $3.48 to $3.56 Now $1.88 −45.98% ▲ +2.30% −4.00% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers